Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

West Pharmaceutical Services (NY: WST )

330.05 -1.57 (-0.47%)
Official Closing Price Updated: 7:00 PM EST, Dec 13, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 516,111
Open 329.68
Bid (Size) 321.54 (1)
Ask (Size) 337.74 (1)
Prev. Close 331.62
Today's Range 324.23 - 330.25
52wk Range 265.00 - 413.70
Shares Outstanding 73,500,000
Dividend Yield 0.24%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
3 Dividend Aristocrats With Long-Term Growth
These 3 Dividend Aristocrats have raised their dividends for over 25 years and have long-term growth potential. 
Via Talk Markets
Topics Stocks / Equities
Why NYSE:WST qualifies as a good dividend investing stock.
Uncovering Dividend Opportunities with WEST PHARMACEUTICAL SERVICES (NYSE:WST). 
Via Chartmill

Performance

YTD
-5.35%
-5.35%
1 Month
-4.06%
-4.06%
3 Month
+9.77%
+9.77%
6 Month
-0.96%
-0.96%
1 Year
-7.81%
-7.81%

More News

Read More
Cameco, Applied Digital, West Pharmaceutical And More On CNBC's 'Final Trades'
Via Benzinga
Looking Into West Pharmaceutical Servs's Recent Short Interest
Via Benzinga
Peering Into West Pharmaceutical Servs's Recent Short Interest
Via Benzinga
Balancing Dividends and Fundamentals: The Case of NYSE:WST.
Via Chartmill
Earnings Outlook For West Pharmaceutical Servs
Via Benzinga
(WST) - Analyzing West Pharmaceutical Servs's Short Interest
Via Benzinga
Exploring NYSE:WST's dividend characteristics.
Via Chartmill
Is NYSE:WST a Good Fit for Dividend Investing?
Via Chartmill
West Pharmaceutical's Q3 Performance Shows Rising Demand For Syringes, Company Boosts Annual Forecast And Dividend
Via Benzinga
UPS Posts Upbeat Q3 Results, Joins Tesla, Celestica, Pool, T-Mobile And Other Big Stocks Moving Higher On Thursday
Via Benzinga
Build-A-Bear Workshop Posts Upbeat Earnings, Joins Affirm, Nutanix, Cooper Companies, Veeva Systems And Other Big Stocks Moving Higher On Thursday
Via Benzinga
Balancing Dividends and Fundamentals: The Case of NYSE:WST.
Via Chartmill
Why NYSE:WST is a Top Pick for Dividend Investors.
Via Chartmill
How Is The Market Feeling About West Pharmaceutical Servs?
Via Benzinga
S&P 500, Nasdaq 100 Mark Seventh Straight Positive Session, Strongest Week Since October 2023: Friday's Top Movers
Via Benzinga
Topics Stocks
Exposures US Equities
Ford, Stellantis And Dell Are Among Top 12 Large Cap Losers Last Week (July 21-July 27): Are The Others In Your Portfolio?
Via Benzinga
WST Stock Earnings: West Pharmaceutical Servs Misses EPS, Misses Revenue for Q2 2024
Via InvestorPlace
Uncovering Dividend Opportunities with NYSE:WST.
Via Chartmill
Peering Into West Pharmaceutical Servs's Recent Short Interest
Via Benzinga
How Is The Market Feeling About West Pharmaceutical Servs?
Via Benzinga
Why the dividend investor may take a look at NYSE:WST.
Via Chartmill
Why Edwards Lifesciences Shares Are Trading Lower? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
WST Stock Earnings: West Pharmaceutical Servs Beats EPS, Beats Revenue for Q1 2024
Via InvestorPlace
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.